The US Food and Drug Administration continues to “aggressively” watch the market for sham COVID-19 medical products, two top agency officials said on 24 February.
The FDA is monitoring the market “for any firms marketing products with fraudulent COVID-19 prevention and treatment claims,” agency commissioner Stephen Hahn wrote in a statement co-authored by Judith...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?